Advances in Molecular Diagnosis of Neurofibromatosis Type 1

被引:26
|
作者
Shofty, Ben [1 ,3 ]
Constantini, Shlomi [1 ,2 ,3 ]
Ben-Shachar, Shay [3 ,4 ]
机构
[1] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Div Neurosurg, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Gilbert Israeli Neurofibromatosis Ctr, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Genet Inst, IL-69978 Tel Aviv, Israel
关键词
PREIMPLANTATION GENETIC DIAGNOSIS; NF1; GENE; MUTATIONS; PHENOTYPE; GENOTYPE; SPECTRUM; INACTIVATION; EXPRESSION; MOSAICISM; STENOSIS;
D O I
10.1016/j.spen.2015.10.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis 1 (NF1) is a common neurocutaneous and tumor predisposing genetic disorder with an autosomal dominant mode of inheritance. NF1 is solely caused by mutations in the NF1 gene, and disease-causing mutations can be found in more than 95% of individuals with a clinical diagnosis. Although NF1 has a distinctive clinical phenotype, it has a highly variable expression, even among individuals from the same family. Identifying the specific mutation does not usually assist in determining disease course and severity, and relatively few genotype-phenotype correlations have thus far been found. This review discusses the basic clinical aspects of NF1 and the current explanations for the high phenotypic variability, and provides the recently detected genotype-phenotype correlations. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 50 条
  • [1] Molecular diagnosis strategies in neurofibromatosis type 1
    Bhouri, R.
    Hebrard, B.
    Wolkenstein, P.
    Funalot, B.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (03): : 247 - 251
  • [2] Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View
    Pasmant, Eric
    Vidaud, Dominique
    EBIOMEDICINE, 2016, 7 : 21 - 22
  • [3] Neurofibromatosis Type 1 Molecular Diagnosis in Turkish Patients
    Bahsi, Taha
    Saat, Hanife
    GAZI MEDICAL JOURNAL, 2020, 31 (03): : 406 - 409
  • [4] NF1 Exon 22 Analysis of Individuals With the Clinical Diagnosis of Neurofibromatosis Type 1
    Muram-Zborovski, Talia M.
    Vaughn, Cecily P.
    Viskochil, David H.
    Hanson, Heather
    Mao, Rong
    Stevenson, David A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (08) : 1973 - 1978
  • [5] Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?
    Pasmant, Eric
    Parfait, Beatrice
    Luscan, Armelle
    Goussard, Philippe
    Briand-Suleau, Audrey
    Laurendeau, Ingrid
    Fouveaut, Corinne
    Leroy, Chrystel
    Montadert, Annelore
    Wolkenstein, Pierre
    Vidaud, Michel
    Vidaud, Dominique
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2015, 23 (05) : 596 - 601
  • [6] The Diagnosis and Management of Neurofibromatosis Type 1
    Ly, K. Ina
    Blakeley, Jaishri O.
    MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (06) : 1035 - +
  • [7] A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands
    van Minkelen, R.
    van Bever, Y.
    Kromosoeto, J. N. R.
    Withagen-Hermans, C. J.
    Nieuwlaat, A.
    Halley, D. J. J.
    van den Ouweland, A. M. W.
    CLINICAL GENETICS, 2014, 85 (04) : 318 - 327
  • [8] Tumor and Constitutional Sequencing for Neurofibromatosis Type 1
    Tong, Schuyler
    Devine, W. Patrick
    Shieh, Joseph T.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [9] The role of miRNAs and lncRNAs in neurofibromatosis type 1
    Khosravi, Teymoor
    Oladnabi, Morteza
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2023, 124 (01) : 17 - 30
  • [10] Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)
    Gomez, Martha
    Batista, Oriana
    REVISTA MEDICA DE CHILE, 2015, 143 (10) : 1320 - 1330